Physician
Anthony Martin Mills M D a Medical Corporation
Anthony Martin Mills M D a Medical Corporation was paid $700K by Medicaid between Jul 2020 and Dec 2024, across 42 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 33% of everything it billed.
33Billing provider infoANTHONY MARTIN MILLS M D A MEDICAL CORPORATION
WEST HOLLYWOOD, CA 90069
WEST HOLLYWOOD, CA 90069
33aNPI1497172043assigned 03/20/2014
33bProvider typeInternal Medicine Physician
28Total paid$700K
24GClaims39,193
24DCodes billed42
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#184 of 2,679
Median peer was paid$13K
This provider vs. median55×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 54 | $100.10 | |
| 2021 | 2,755 | $47K | |
| 2022 | 8,898 | $167K | |
| 2023 | 10,227 | $185K | |
| 2024incomplete | 17,259 | $301K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 33% | 8,940 | 3,415 | $233K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 32% | 8,756 | 3,396 | $226K |
| 87536 | 7.7% | 749 | 738 | $54K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.3% | 1,165 | 1,119 | $37K |
| 99000 | 2.1% | 4,250 | 3,989 | $15K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.1% | 752 | 744 | $14K |
| 86703 | 2.1% | 1,599 | 1,557 | $14K | |
| 86803 | 2.0% | 1,137 | 1,115 | $14K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.9% | 190 | 183 | $14K |
| 80053 | Comprehensive metabolic panel | 1.6% | 1,287 | 1,270 | $11K |
| 86592 | 1.5% | 3,138 | 3,038 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.3% | 753 | 721 | $9K |
30 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 280 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 133 | $4K |
| 80061 | Lipid panel | <1% | 365 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 29 | $4K |
| 84403 | <1% | 163 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 26 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 615 | $3K |
| 81003 | <1% | 1,231 | $3K | |
| 82670 | <1% | 87 | $2K | |
| 86780 | <1% | 183 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 234 | $2K |
| 90686 | <1% | 70 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 90 | $2K |
| 82652 | <1% | 46 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 200 | $1K |
| 86706 | <1% | 102 | $938.03 | |
| 86708 | <1% | 88 | $923.03 | |
| 87340 | <1% | 97 | $855.02 | |
| 84439 | <1% | 104 | $783.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 52 | $730.50 |
| 86704 | <1% | 67 | $685.63 | |
| 84153 | <1% | 41 | $663.79 | |
| 90656 | <1% | 17 | $443.53 | |
| 86593 | <1% | 110 | $425.86 | |
| 36416 | <1% | 926 | $331.94 | |
| 86361 | <1% | 12 | $282.72 | |
| 91320 | <1% | 17 | $131.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,046 | $50.60 |
| 90480 | <1% | 31 | $40.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 15 | $0.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLS, ANTHONY (PRESIDENT)